Page last updated: 2024-10-26

edrophonium and Demyelinating Diseases

edrophonium has been researched along with Demyelinating Diseases in 2 studies

Edrophonium: A rapid-onset, short-acting cholinesterase inhibitor used in cardiac arrhythmias and in the diagnosis of myasthenia gravis. It has also been used as an antidote to curare principles.
edrophonium : A quaternary ammonium ion that is N-ethyl-N,N-dimethylanilinium in which one of the meta positions is substituted by a hydroxy group. It is a reversible inhibitor of cholinesterase, with a rapid onset (30-60 seconds after injection) but a short duration of action (5-15 minutes). The chloride salt is used in myasthenia gravis both diagnostically and to distinguish between under- or over-treatment with other anticholinesterases. It has also been used for the reversal of neuromuscular blockade in anaesthesia, and for the management of poisoning due to tetrodotoxin, a neuromuscular blocking toxin found in puffer fish and other marine animals.

Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aita, JF1
Snyder, DH1
Reichl, W1
Welch, LK1
Appenzeller, O1
Bicknell, JM1

Other Studies

2 other studies available for edrophonium and Demyelinating Diseases

ArticleYear
Myasthenia gravis and multiple sclerosis: an unusual combination of diseases.
    Neurology, 1974, Volume: 24, Issue:1

    Topics: Adult; Brain; Demyelinating Diseases; Diplopia; Edrophonium; Electroencephalography; Female; gamma-G

1974
Peripheral neuropathy with myokymia, sustained muscular contraction, and continuous motor unit activity.
    Neurology, 1972, Volume: 22, Issue:2

    Topics: Action Potentials; Adult; Calcium; Decamethonium Compounds; Demyelinating Diseases; Edrophonium; Ele

1972